114
Participants
Start Date
September 30, 2013
Primary Completion Date
November 30, 2013
Study Completion Date
November 30, 2013
rosuvastatin 40 mg tablet
Single oral dose of 40 mg (1 x 40 mg tablet) rosuvastatin (Crestor®) (Day 1).
Epanova™ QD (2 x 1 g capsules)
Multiple oral doses of 2 g (2 x 1 g capsules) Epanova™ QD for 10 consecutive days (Days 4 to 13)
Multiple doses of 4 g Epanova™ with single of rosuvastatin 40 mg dose
Multiple oral doses of 4 g Epanova™ QD for 13 consecutive days with coadministration of single 40 mg oral dose of rosuvastatin (Crestor®) with the 11th dose of Epanova™ on Day 24
Multiple (20) oral doses of 2 g Vascepa® every 12 hours
Multiple oral doses of 2 g (2 x 1 g capsules) Vascepa® every 12 hours for 20 consecutive days (Days 1 to 20).
Celerion, Neptune City
Lead Sponsor
AstraZeneca
INDUSTRY